Cargando…

Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13

Detalles Bibliográficos
Autores principales:	Falvella, Ana Caroline Brambilla, Smith, Bradley Joseph, Silva-Costa, Licia C., Valença, Aline G. F., Crunfli, Fernanda, Zuardi, Antonio W., Hallak, Jaime E., Crippa, José A., de Almeida, Valéria, Martins-de-Souza, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672415/ https://www.ncbi.nlm.nih.gov/pubmed/34924956 http://dx.doi.org/10.3389/fnmol.2021.814907

Ejemplares similares

Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Falvella, Ana Caroline Brambilla, et al.
Publicado: (2021)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016)

Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
por: Gouvêa-Junqueira, Danielle, et al.
Publicado: (2020)

Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
por: Breuer, Aviva, et al.
Publicado: (2016)

Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
por: Breuer, Aviva, et al.
Publicado: (2016)

Reappraisal of Human HOG and MO3.13 Cell Lines as a Model to Study Oligodendrocyte Functioning
por: De Kleijn, Kim M. A., et al.
Publicado: (2019)

F198. EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
por: de Meneses-Gaya, Carolina, et al.
Publicado: (2020)

Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination
por: Zirngibl, Martin, et al.
Publicado: (2022)

The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
por: Bolsoni, Lívia Maria, et al.
Publicado: (2022)

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
por: Vuolo, Francieli, et al.
Publicado: (2015)

Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury
por: Soares, Rodrigo Zon, et al.
Publicado: (2015)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
por: Linares, Ila M. P., et al.
Publicado: (2018)

Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
por: Peres, Fernanda F., et al.
Publicado: (2016)

Ubiquitin–proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia
por: Seabra, Gabriela, et al.
Publicado: (2020)

Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload
por: da Silva, Vanessa Kappel, et al.
Publicado: (2018)

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
por: Ferreira-Junior, Nilson C., et al.
Publicado: (2019)

EBI2 Is Temporarily Upregulated in MO3.13 Oligodendrocytes during Maturation and Regulates Remyelination in the Organotypic Cerebellar Slice Model
por: Velasco-Estevez, Maria, et al.
Publicado: (2021)

RNA-Seq Transcriptome Analysis of Differentiated Human Oligodendrocytic MO3.13 Cells Shows Upregulation of Genes Involved in Myogenesis
por: Głowacka, Aleksandra, et al.
Publicado: (2022)

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
por: Zuardi, Antonio W., et al.
Publicado: (2017)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
por: Loss, Cássio Morais, et al.
Publicado: (2021)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
por: Crippa, José A., et al.
Publicado: (2018)

Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model
por: Callejas, G.H., et al.
Publicado: (2018)

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)
por: Souza, José Diogo R., et al.
Publicado: (2022)

Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain Sensitivity
por: Macêdo-Souza, Carolina, et al.
Publicado: (2023)

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
por: Peres, Fernanda F., et al.
Publicado: (2018)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
por: Peres, Fernanda F., et al.
Publicado: (2016)

Cannabidiol induces autophagy via ERK1/2 activation in neural cells
por: Vrechi, Talita A. M., et al.
Publicado: (2021)

Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
por: Genaro, Karina, et al.
Publicado: (2017)

Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
por: Souza, José Diogo S., et al.
Publicado: (2022)

Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
por: Crippa, José A., et al.
Publicado: (2021)

Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
por: Do Val-da Silva, Raquel A., et al.
Publicado: (2017)

Gas6 Increases Myelination by Oligodendrocytes and Its Deficiency Delays Recovery following Cuprizone-Induced Demyelination
por: Binder, Michele D., et al.
Publicado: (2011)

Brain-Derived Neurotrophic Factor Deficiency Restricts Proliferation of Oligodendrocyte Progenitors Following Cuprizone-Induced Demyelination
por: Tsiperson, Vladislav, et al.
Publicado: (2015)

Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
por: Fabris, Débora, et al.
Publicado: (2022)

Marijuana, feijoada and the debate on drug legalization
por: Crippa, José A. S., et al.
Publicado: (2013)

Behavioral and Neurobiological Changes in C57BL/6 Mouse Exposed to Cuprizone: Effects of Antipsychotics
por: Xu, Haiyun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ed23j7th2e1lciv3sl1auafrlu